Author Details

Samtsov, Alexey V.

Issue Section Title File
Vol 96, No 2 (2020) EDITORIAL Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19 PDF
(Rus)
Vol 96, No 2 (2020) DRUG TREATMENT IN DERMATOVENEROLOGY Isotretinoin — 40 Years in Dermatology PDF
(Rus)
Vol 96, No 4 (2020) ORIGINAL STUDIES Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses PDF
(Rus)
Vol 96, No 3 (2020) DRUG TREATMENT IN DERMATOVENEROLOGY New technologies in topical acne therapy PDF
(Rus)
Vol 97, No 2 (2021) ORIGINAL STUDIES Features of the cytokine profile and the effectiveness of radical treatment of focal infection in patients with psoriasis PDF
(Rus)
Vol 96, No 6 (2020) ORIGINAL STUDIES Experience of using an emollient with an anti-inflammatory effect based on ammonium glycyrrhizinate in the complex therapy of patients with atopic dermatitis PDF
(Rus)
Vol 97, No 2 (2021) DRUG TREATMENT IN DERMATOVENEROLOGY Perspective trends of topical therapy of patients with psoriasis PDF
(Rus)
Vol 97, No 2 (2021) REVIEWS Revisiting the question of pemphigus classification PDF
(Rus)
Vol 97, No 3 (2021) ORIGINAL STUDIES The new external drug for the treatment of psoriasis based on inhibition of serine proteases PDF
(Rus)
Vol 97, No 4 (2021) ORIGINAL STUDIES Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial PDF
(Rus)
Vol 97, No 4 (2021) REVIEWS Revisiting the question of cutaneous vasculitis classification PDF
(Rus)
Vol 98, No 2 (2022) ORIGINAL STUDIES Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies